Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioCorRx Enters Mfg. Partnership with IRISYS | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

BioCorRx Enters Mfg. Partnership with IRISYS

For manufacturing of BICX102 naltrexone implant for treatment of opioid use disorder

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioCorRx, a developer and provider of solutions in the treatment of substance use disorders, has engaged IRISYS, LLC, a contract pharmaceutical product development and manufacturing services company, for the development and manufacturing of BICX102, a multi-month sustained release naltrexone implant. The company plans to conduct clinical trials and seek FDA approval for BICX102 as a treatment for opioid and alcohol use disorders.
 
“We look forward to partnering with such a reputable partner as IRISYS to manufacture our naltrexone implant,” said Brady Granier, chief executive officer and president, BioCorRx. “Having received the National Institute on Drug Abuse grant award last month and following a pre-IND meeting we had with the FDA last year, we are now in a position to begin the manufacturing and development process for our lead pharmaceutical candidate, BICX102. IRISYS brings valuable experience beyond manufacturing that should also contribute to our success as we move forward through the clinical and regulatory process for BICX102.”
 
Robert Giannini, chief science and technology officer, IRISYS,” said, “IRISYS is pleased to contribute its expertise to the development of BICX102, which promises to be a significant factor in addiction recovery and we believe it will aid in the effort to combat the national opioid crisis.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics